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 The introduction of highly active antiretroviral therapy 
(HAART) has radically changed the natural history of HIV infection and significantly extended the life-
span of patients living with AIDS. The increased mean life-span has given rise to long-term complications 
of HIV such as metabolic complication, cardiovascular disease and bone mineral density changes. High 
rates of abnormalities of bone mineralisation have been reported in HIV-infected patients as assessed by 
the bone mineral density (BMD) using the World Health Organisation (WHO) criteria
Methods:
This is a narrative review of selected literatures following a detailed search of existing literatures and on-
line database
Conclusion:
The prevalence of osteoporosis and osteopenia in HIV-infected individuals is more than three times 
compared with HIV- uninfected individuals.
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Since the beginning of the Human immunodeficiency virus (HIV) epidemic in the early 1990s, more than 
60 million people have been infected with the virus and nearly 30 million people have died of Acquired 
Immune Deficiency syndrome (AIDS) worldwide.
Introduction 
Prior to the advent of potent antiretroviral therapy, 
the most common bone disorders in HIV-infected 
patients were complications of infections and 
malignancies. In the current HIV treatment era, 
with prolongation of survival and the decreased 
incidence of opportunistic complications, 
osteopenia and osteoporosis have emerged as the 
1most common bone disorders in this population.
  The high prevalence of bone 
demineralization among HIV-infected patients has 
3-5
been described in multiple studies.
 
HIV mainly replicates in CD4+ T lymphocytes and 
monocyte /macrophages  caus ing severe  
immunological impairment. In addition to the 
immune system, HIV infection affects tissues and 
organs such as kidney, liver, the central nervous 
system, heart and bone showing a complex 
2
pathogenesis.  The advent and widespread use of 
highly active antiretroviral therapy (HAART) has 
dramatically changed the course of HIV infection 
from a fatal infection to a chronic and relatively 
manageable disease.
Given the complex metabolic complications of HIV 
infection and its treatment, the decreased bone 
mineralization seen in a large percentage of HIV-
infected patients is likely the result of 
heterogeneous causes and interplay of host, viral, 
and specific antiretroviral factors. Bone is 
constantly undergoing remodelling in a 
synchronized balance between resorption and 
formation, which can become unregulated during 
6-7HIV infection.  
The present article reviews the epidemiology, 
possible pathogenesis, and management of 
osteopenia and osteoporosis in HIV infection.
Bone Metabolism 
Bone is a specialized connective tissue 
characterized by hardness and plasticity, consisting 
of cells immersed in a mineralized extracellular 
matrix. There are three types of cells in mature bone 
The major bone lesions detectable 
in HIV patients are related to bone demineralization 
(osteopenia/osteoporosis and osteomalacia) and 
osteonecrosis 
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tissue: osteoblasts, osteocytes, and osteoclasts. 
Osteoblasts and osteocytes are involved in the 
deposition of bone matrix.  These cells produce 
collagen type I, which is then calcified. These cells 
also produce non-collagenous proteins, as well as 
regulatory factors. The extracellular matrix can be 
subdivided into organic matrix composed of 
collagen fibers and ground substance, and 
inorganic matrix composed mainly of a complex of 
calcium and phosphate in the form of 
hydroxyapatite [Ca (PO ) (OH) ]. The inorganic 10 4 6 2
portion of the matrix is what gives bone its density, 
and accounts for approximately 65% of the 
extracellular matrix. Osteoblasts are located at the 
surfaces of bone tissue, while osteoclasts are 
located within the calcified matrix of bones. Both 
osteoclasts and osteoblasts originate in the marrow. 
The marrow progenitors of osteoclasts are of the 
hematopoietic lineage, whereas the progenitors of 
osteoblasts are of the mesenchymal lineage of the 
8marrow stroma .  Osteoblasts, characterized by the 
ability to secrete bone matrix, and osteoclasts, 
responsible for bone resorption are involved in 
bone tissue regulation. Both osteoblasts and 
osteoclasts act on bone homeostasis through a 
continuous remodelling process, necessary both to 
maintain calcium and phosphates homeostasis and 
to promote body adaptation to external tensional 
forces. The bone remodelling process begins with 
the proliferation and activation of osteoclasts on the 
bone surface and is controlled by systemic 
hormones such as calcitonin, parathormone, 
estrogens and local factors, most of them involved 
in inflammatory responses such as IL-1, IL-6, TNF-
9á and prostaglandins.  Under normal conditions, 
bone remodelling proceeds in cycles in which 
osteoclasts adhere to bone and subsequently 
remove it by acidification and proteolytic 
digestion. Shortly after the osteoclasts have left the 
resorption site, osteoblasts invade the area and 
begin the process of forming new bone by secreting 
osteoid (a matrix of collagen and other proteins), 
which is eventually mineralized. After bone 
formation has ceased, the surface of the bone is 
covered by lining cells, a distinct type of terminally 
differentiated osteoblastsBone is continually 
remodelled throughout life because bones sustain 
recurring microtrauma. Bone remodelling occurs at 
discrete sites within the skeleton and proceeds in an 
orderly fashion. Bone resorption is always 
followed by bone formation, a phenomenon 
referred to as coupling. In osteoporosis, this 
coupling mechanism is thought to be unable to keep 
up with the constant microtrauma to trabecular 
bone. In adults, approximately 25% of trabecular 
bone is resorbed and replaced every year, compared 
with only 3% of cortical bone. Osteoclasts require 
weeks to resorb bone, whereas osteoblasts need 
months to produce new bone. Therefore, any 
process that increases the rate of bone remodelling 
10
results in net bone loss over time.
Osteoporosis results from bone loss due to age-
related changes in bone remodelling as well as 
extrinsic and intrinsic factors that exaggerate this 
process. During growth, the skeleton increases in 
size by linear growth and by apposition of new bone 
tissue on the outer surfaces of the cortex. This 
reaches a peak between the ages of 20-30 years but 
falls thereafter in both sexes. Many factors regulate 
bone mass in normal individual. Genetic factors are 
the single most important influence on bone mineral 
density. Multiple genes are involve and they include 
vitamin D receptor; type I collagen, the estrogen 
receptor (ER), interleukin (IL) 6; and insulin-like 
growth factor (IGF) I]. Nutrition and lifestyle also 
play an important role in osteoporosis as well as 
HIV infection
Epidemiology And Pattern Of Bone Mineral 
Density Disorders
Bone mineral density (BMD) in a patient is related 
to peak bone mass and subsequently, bone loss. The 
World Health Organization (WHO) has established 
the following definitions of osteoporosis based on 
BMD measurements
?Normal - BMD within 1 standard deviation 
(SD) of the mean bone density for a young 
adult  (T-score at -1 and above)
?Low bone mass (osteopenia) - BMD 
between 1-2.5 SD below the mean for a 
young adult  (T-score between -1 and -2.5)
?Osteoporosis - BMD 2.5 SD or more below 
the normal mean for a young adult (T-score 
at or below -2.5)
?Severe or "established" osteoporosis - BMD 
2.5 SD or more below the normal mean for 
young adult females (T-score at or below -
2.5) in a patient who has already 
experienced 1 or more fractures 
The T-score is the bone density compared with the 
BMD of control subjects who are at their peak 
BMD. The Z-score reflects a bone density 
compared with that of patients matched for age and 
11sex.
Osteoporosis is by far the most common metabolic 
bone disease in the world and is estimated to affect 
12 
over 200 million people worldwide. An estimated 
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75 million people in Europe, the United States, and 
13 
Japan have osteoporosis. One in 3 women older 
than 50 years will eventually experience 
osteoporotic fractures, as will 1 in 5 men. By 2050, 
the worldwide incidence of hip fracture is projected 
to increase by 240% in women and 310% in 
14men. According to the National Osteoporosis 
Foundation (NOF), 10 million Americans have 
osteoporosis. Another 34 million have low bone 
mass, which leaves them at increased risk for 
15osteoporosis. Osteoporosis is thought rarely to 
16 
affect blacks and hip fractures are ten times less 
Prevalent in these populations. Osteoporotic 
fractures are also much less prevalent in Afro-
Americans in the USA, where the observation is 
readily explained, based on an approximate 15% 
higher BMD in this population compared to 
Caucasians
Osteoporosis( a consequence of reduced BMD) can 
occur in persons of all races and ethnicities. In 
general, however, whites (especially of northern 
European descent) and Asians are at increased risk. 
Melton et al reported that the prevalence of hip 
fractures is higher in white populations, regardless 
of geographic location. Another study indicated 
that the incidence of hip fractures was lower among 
African Americans in the United States and South 
Africa compared to age-matched white populations 
17, 18 
within the same continent. Risk for osteoporosis 
increases with age, as BMD declines. Women are at 
a significantly higher risk for osteoporosis with a 
15 female-to-male ratio of 4:1. A study done in 
Nigeria, also revealed the age related decline in 
BMD although at a slower rate compared to the 
19
Caucasians.  
RISK FACTORS FOR BMD
The hallmark of osteoporosis is a reduction in 
skeletal mass caused by an imbalance between 
bone resorption and bone formation and this 
imbalance have been shown to be exaggerated 
1,3-5
during HIV infection  
Risk factors associated with increased bone loss 
may be considered as endogenous or exogenous. 
Endogenous factors include ethnicity, female 
gender, advancing age and family history of 
f r a c t u r e .  E x o g e n o u s  f a c t o r s  i n c l u d e  
hypogonadism, glucocorticoid treatment, low 
BMI, previous fracture, smoking, immobilization, 
excess alcohol and low vitamin D. Other factors 
contributing to reduced BMD include late 
menarche, early menopause, and postmenopausal 
state, drugs like anticonvulsants, thyroid 
supplements, heparin, chemotherapeutic agents, 
antiretroviral therapy, oral contraceptive and 
calcium deficiency
VIROLOGY OF HIV
Figure 1: structure of HIV1 virus
The HIV was first isolated in 1983 and was shown 
20
to be the cause of AIDS. The two types of HIV 
(HIV-1and HIV-2) belong to the lentivirus group of 
the retrovirus family. HIV-1 is widely distributed 
and accounts for about 95% of all HIV infections 
worldwide. HIV-2 was isolated in 1986 and it is 
confined to West Africa, Portugal and countries 
with historical links to Portugal. In Nigeria, HIV-1 
accounts for >95% of the total HIV infections and 
21almost 99% of all AIDS cases.  The predominance 
of HIV-1 can be partly explained by its higher 
infectivity and transmission efficiency compared to 
HIV-2.
HIV-1 has genes that encode the structural proteins 
of the virus: gag encodes the proteins that form the 
core of the virion (including p24 antigen); pol 
encodes the enzymes responsible for protease 
processing of viral proteins, reverse transcription, 
and integration; and env encodes the envelope 
glycoproteins. HIV-1 is more complex than other 
retroviruses, particularly those of the non-primate 
group, in that it also contains at least six other genes 
(tat, rev, nef, vif, vpr, and vpu), which code for 
proteins involved in the modification of the host cell 
to enhance virus growth and the regulation of viral 
gene expression. Several of these proteins are 
thought to play a role in the pathogenesis of HIV 
disease. The major difference between the genomes 
of HIV-1 and HIV-2 is the fact that HIV-2 lacks the 
vpu gene and has a vpx gene not contained in HIV-
20
1.
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There are three groups of HIV-1: group M (major), 
which is responsible for most of the infections in 
the world; group O (outlier), a relatively rare viral 
form found originally in Cameroon, Gabon, and 
France; and group N (new), first identified in a 
Cameroonian woman with AIDS; only a few cases 
20 of the latter have been identified. Group M strains 
have huge diversity with sub-classification into A-
K subtypes. Subtype A is responsible for 80% of 
HIV cases in West Africa while there is 
predominance of subtype B in Europe and North 
30
America. Recombination of viral material 
generates an array of circulating recombinant 
forms (CRF) which increases the genetic diversity 
seen in HIV-1. The prevalent subtypes in Nigeria 
31are A, G and the CRF A/G ; A is predominantly 
found in the north, G in the south, while the CRF 
A/G is found in the middle belt zone of the 
22country.
HIV AND THE BONE  
THE ROLE OF HIV INFECTION
Early studies on 
HIV/osteoblasts interaction to determine whether 
HIV is able to infect osteoblasts, have yielded 
24, 25
controversial results.
Several HIV proteins may affect the functionality 
and maturation of osteoblasts by inducing 
apoptotic stimuli in mesenchymal stem cells, 
which are precursors of osteoblasts. In particular, 
HIV-1-gp120 and p55gag can reduce bone alkaline 
phosphatase activity and calcium deposition by 
osteoblasts, and Rev and p55gag affect the 
differentiation of mesenchymal stem cells toward 
osteoblastic lineage. In addition it has been shown 
that HIV-1 triggers apoptosis in primary 
26, 27
osteoblast.
The most important regulatory mechanism of 
o s t e o c l a s t / o s t e o b l a s t  a c t i v i t y  i s  t h e  
28
OPG/RANKL/RANK system.  RANKL and OPG 
29are produced by lymphocytes  other than 
osteoblasts, and increased levels of these cytokines 
are common in diseases characterized by persistent 
30
immune activation  that can determine bone 
26,31,loss.   Interestingly, RANKL can be also up-
32, regulated by viral proteins such as gp120 and Vpr
33
 suggesting an osteoclastic hyper-activation in the 
bone compartment with bone homeostasis 
imbalance. 
The mechanism of loss of bone mass in HIV 
23 infection is poorly understood.
In addition to the direct role of HIV on osteoblast 
and osteoclast interaction, HIV has been associated 
34
with some risk factors for osteoporosis  such as 
under nutrition and malabsorption pathologies 
which can influence levels of vitamin D and 
calcium or endocrine complications, such as 
35
androgen and estrogen deficiency.
The extended course of viral infection and 
prolonged HAART treatment has displayed several 
degenerative aspects of HIV-related disease 
regarding different cell lineages. In particular, HIV 
infection per se and HAART therapy can directly 
affect the homeostasis of bone tissue. Even though 
it has been shown that antiretroviral therapy may 
play an important role in bone loss, a significant 
decrease of bone density has been observed in HIV 
1,4, 36 positive HAART naïve patients . A marked 
decrease in bone turnover and reduced bone 
formation is more evident in patients with advanced 
37-38
HIV disease  and a significant decrease of 
osteocalcin serum levels and increase in matrix 
degradation products are reported in HIV-positive 
39individuals.
A recent study performed on a large number of HIV-
1 infected patients reported a high percentage of 
osteopenia and osteoporosis (53.7% and 26.8%) 
suggesting a direct role of HIV in bone mass 
40derangement.  A recent work comparing bone 
mineral density in 152 HIV-seropositive and 100 
healthy women disclosed a highly significant 
(p<0.0001) decrease in mineralization in HIV 
subjects, which remained significant also after 
41
controlling for race.  A Canadian Multicentre 
Study for Osteoporosis reported higher incidences 
of fractures in HIV patients than in a control group 
42(26.1% vs 17.7%) .
Figure 2: Factors that may contribute to decreased bone 
mineral density in HIV  infected patients
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THE ROLE OF HAART
The true impact of HIV-1 infection and/or HAART 
therapy in the development of BMD abnormalities 
43
remains largely unconfirmed . The association 
between osteopenia and PIs emerged in several in-
vitro models and seems to have a different etiology 
4 4 , 4 5depend ing  on  spec i f i c  molecu les .  
Antiretrovirals like tenofovir, ritonavir and the 
NRTI have been implicated in bone mineral 
11, 44-49
density changes in HIV infected patients .
In addition, the HAART/bone interaction has been 
studied to determine whether multidrug treatment 
50-51
is involved in BMD decrease.  Despite a high 
variability related to specific drug class and 
treatment duration, HAART seems to have a 
pivotal role, especially when it includes a protease 
3,52
inhibitor (PI) .  Conversely, other reports failed to 
reveal any influence of HAART on bone condition, 
finding no differences in BMD reduction between 
37,53 naive and treated patient.  A dual HAART-
induced effect has been hypothesized. The drugs 
initially exacerbate abnormalities in bone 
54
homeostasis  and then the restoration of some 
cytokine networks allows the normalization of 
bone remodelling process. 
Bone metabolism alterations can be determined by 
functional damage to other organs involved in 
55 56
bone homeostasis such as liver  or kidney  
Moreover, PIs can impair vitamin D synthesis in 
vitro, by suppressing the activity of several 
57enzymes involved in its synthesis and catabolism  
inhibiting  osteoblasts anabolic activity. Hence, the 
control of antiretroviral toxicity and the 
management of secondary lesions due to life-long 
patient treatment and the slower evolution of HIV 
infection represent a pivotal issue for the clinical 
and therapeutic approach to HIV positive patients.
MANAGEMENT
No data are yet available to guide the clinical 
m a n a g e m e n t  o r  p r e v e n t i o n  o f  
osteopenia/osteoporosis in HIV-infected patients. 
It is reasonable to recommend weight-bearing 
exercise, decreased alcohol consumption, smoking 
cessation, and the treatment of reversible factors 
summarized in figure 2. Vitamin D and calcium 
supplementation may also be appropriate. The role 
of estrogen, selective estrogen receptor modulators 
is uncertain, and some of these treatment 
approaches are presently under study. 
Bisphosphonates have been shown to be a safe, 
convenient, and effective option for treatment of 
osteopenia or osteoporosis in HIV-infected 
58
individuals on HAART.  
A possible future direction in the 
treatment of osteoporosis may be the use of the anti-
RANKL monoclonal antibody (denosumab).
Bone derangement is a major clinical complication 
in the course of HIV infection. The advent of 
HAART has led to a longer life expectancy and 
therefore HIV/HAART-related bone disease is 
destined to increase, enhancing the physiological 
age-related bone loss.  The number of HIV patients 
with bone disease and silent fractures can be 
expected to increase dramatically in the next few 
years because these patients also have two other 
potentially worsening factors: HIV itself and 
antiretroviral therapy. Hence, antiretroviral therapy 
must be accompanied by the clinical management 
of HIV/HAART-related bone disease to reduce the 
risk of osteoporosis and fractures in these patients.
2. Levy JA. HIV pathogenesis: 25 years of 
progress and persistent challenges. AIDS 
2009; 23:147160.
Retrospective data have 
suggested that anabolic steroids and growth 
hormone, when given for HIV-associated wasting 
or lipodystrophy, respectively, do not significantly 
59
affect BMD.  
Conclusion 
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